Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jaime Shaw, Christopher Harvey, Catherine Richards & Christopher Kim. (2019) Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database. Leukemia & Lymphoma 60:13, pages 3235-3243.
Read now
Read now
Gustaf Hedström, Stefan Peterson, Mattias Berglund, Mats Jerkeman & Gunilla Enblad. (2015) Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma – a Swedish population-based study. Acta Oncologica 54:6, pages 924-932.
Read now
Read now
Gustaf Hedström, Oskar Hagberg, Mats Jerkeman & Gunilla Enblad. (2015) The impact of age on survival of diffuse large B-cell lymphoma – a population-based study. Acta Oncologica 54:6, pages 916-923.
Read now
Read now
Catherine Terret, Gilles Albrand, Muriel Rainfray & Pierre Soubeyran. (2015) Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review. Expert Review of Hematology 8:3, pages 329-341.
Read now
Read now
Articles from other publishers (10)
Marguerite Briand, Stephane Gerard, Martin Gauthier, Marie Garric, Zara Steinmeyer & Laurent Balardy. (2021) Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B‐cell lymphoma on survival: A systematic review. European Journal of Haematology 108:1, pages 3-17.
Crossref
Crossref
T. Wästerlid, M. Mohammadi, K. E. Smedby, I. Glimelius, M. Jerkeman, M. Bottai & S. Eloranta. (2018) Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B‐cell lymphoma: a Swedish lymphoma register study. Journal of Internal Medicine 285:4, pages 455-468.
Crossref
Crossref
Xin-Yu Zhang, Jin-Hua Liang, Li Wang, Hua-Yuan Zhu, Wei Wu, Lei Cao, Lei Fan, Jian-Yong Li & Wei Xu. (2018) DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma. Journal of Cancer Research and Clinical Oncology 145:1, pages 117-127.
Crossref
Crossref
Emilia Pardal, Eva Díez Baeza, Queralt Salas, Tomás García, Juan M. Sancho, Encarna Monzón, José M. Moraleda, Raúl Córdoba, Fátima de la Cruz, José A. Queizán, María J. Rodríguez, Belén Navarro, José A. Hernández, Rosana Díez, María Vahi, María C. Viguria, Miguel Canales, María J. Peñarrubia, Tomás J. González-López, Santiago Montes-Moreno, Eva González-Barca, Dolores Caballero & Alejandro Martín. (2018) A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group. American Journal of Hematology 93:7, pages 867-873.
Crossref
Crossref
Fredrik Ellin, Mats Jerkeman, Jenny Törnqvist, Lars Brudin & Thomas Relander. (2018) Impact of comorbidity on survival in peripheral T-cell lymphomas: A Swedish Lymphoma Registry study. Hematological Oncology 36:1, pages 159-165.
Crossref
Crossref
Giuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, Elena Ranucci, Massimo Federico, Marta Di Nicola, Isaia Antonio Luca Zecca & Francesco Angrilli. (2018) Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study. Hematological Oncology 36:1, pages 44-48.
Crossref
Crossref
Sridhar Chaganti, Tim Illidge, Sally Barrington, Pam Mckay, Kim Linton, Kate Cwynarski, Andrew McMillan, Andy Davies, Simon Stern & Karl Peggs. (2016) Guidelines for the management of diffuse large B-cell lymphoma. British Journal of Haematology 174:1, pages 43-56.
Crossref
Crossref
Diana Nolasco-Medina, Nancy Reynoso-Noveron, Alejandro Mohar-Betancourt, Alejandro Aviles-Salas, Osvaldo García-Perez & Myrna Candelaria. (2016) Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico. BioMed Research International 2016, pages 1-10.
Crossref
Crossref
M. W. M. van der Poel, W. J. Mulder, G. J. Ossenkoppele, E. Maartense, M. Hoogendoorn, P. Wijermans & H. C. Schouten. (2015) Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Annals of Hematology 94:8, pages 1373-1379.
Crossref
Crossref
Jessica N. Williams, Ashish Rai, Joseph Lipscomb, Jean L. Koff, Loretta J. Nastoupil & Christopher R. Flowers. (2015) Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma. Cancer 121:11, pages 1800-1808.
Crossref
Crossref